These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18550671)

  • 21. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
    von Hahn T; Yoon JC; Alter H; Rice CM; Rehermann B; Balfe P; McKeating JA
    Gastroenterology; 2007 Feb; 132(2):667-78. PubMed ID: 17258731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
    Morin TJ; Broering TJ; Leav BA; Blair BM; Rowley KJ; Boucher EN; Wang Y; Cheslock PS; Knauber M; Olsen DB; Ludmerer SW; Szabo G; Finberg RW; Purcell RH; Lanford RE; Ambrosino DM; Molrine DC; Babcock GJ
    PLoS Pathog; 2012; 8(8):e1002895. PubMed ID: 22952447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus.
    Beard MR; Abell G; Honda M; Carroll A; Gartland M; Clarke B; Suzuki K; Lanford R; Sangar DV; Lemon SM
    Hepatology; 1999 Jul; 30(1):316-24. PubMed ID: 10385673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras.
    Yanagi M; Purcell RH; Emerson SU; Bukh J
    Virology; 1999 Sep; 262(1):250-63. PubMed ID: 10489358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
    Kachko A; Kochneva G; Sivolobova G; Grazhdantseva A; Lupan T; Zubkova I; Wells F; Merchlinsky M; Williams O; Watanabe H; Ivanova A; Shvalov A; Loktev V; Netesov S; Major ME
    Vaccine; 2011 Dec; 30(1):69-77. PubMed ID: 22041300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8⁺ T cells in early viral evolution.
    Callendret B; Bukh J; Eccleston HB; Heksch R; Hasselschwert DL; Purcell RH; Hughes AL; Walker CM
    J Virol; 2011 Nov; 85(22):11833-45. PubMed ID: 21900166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus.
    Johansson DX; Voisset C; Tarr AW; Aung M; Ball JK; Dubuisson J; Persson MA
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16269-74. PubMed ID: 17911260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.
    Forns X; Thimme R; Govindarajan S; Emerson SU; Purcell RH; Chisari FV; Bukh J
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13318-23. PubMed ID: 11078521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
    Lavillette D; Morice Y; Germanidis G; Donot P; Soulier A; Pagkalos E; Sakellariou G; Intrator L; Bartosch B; Pawlotsky JM; Cosset FL
    J Virol; 2005 May; 79(10):6023-34. PubMed ID: 15857988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus.
    Meuleman P; Bukh J; Verhoye L; Farhoudi A; Vanwolleghem T; Wang RY; Desombere I; Alter H; Purcell RH; Leroux-Roels G
    Hepatology; 2011 Mar; 53(3):755-62. PubMed ID: 21319203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool.
    Bukh J; Apgar CL; Engle R; Govindarajan S; Hegerich PA; Tellier R; Wong DC; Elkins R; Kew MC
    J Infect Dis; 1998 Oct; 178(4):1193-7. PubMed ID: 9806059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
    Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity.
    Weiner AJ; Paliard X; Selby MJ; Medina-Selby A; Coit D; Nguyen S; Kansopon J; Arian CL; Ng P; Tucker J; Lee CT; Polakos NK; Han J; Wong S; Lu HH; Rosenberg S; Brasky KM; Chien D; Kuo G; Houghton M
    J Virol; 2001 Aug; 75(15):7142-8. PubMed ID: 11435595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus.
    Youn JW; Hu YW; Tricoche N; Pfahler W; Shata MT; Dreux M; Cosset FL; Folgori A; Lee DH; Brotman B; Prince AM
    J Virol; 2008 Nov; 82(21):10896-905. PubMed ID: 18753204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyses of amino acid sequences in hypervariable region-1 of hepatitis C virus (HCV) in sera from chimpanzees infected three times with the same HCV strain.
    Sugitani M; Nishimura S; Mizuno K; Shikata T
    J Med Primatol; 2010 Feb; 39(1):1-8. PubMed ID: 19811605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.
    Meunier JC; Engle RE; Faulk K; Zhao M; Bartosch B; Alter H; Emerson SU; Cosset FL; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4560-5. PubMed ID: 15767578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune protection against reinfection with nonprimate hepacivirus.
    Pfaender S; Walter S; Grabski E; Todt D; Bruening J; Romero-Brey I; Gather T; Brown RJ; Hahn K; Puff C; Pfankuche VM; Hansmann F; Postel A; Becher P; Thiel V; Kalinke U; Wagner B; Bartenschlager R; Baumgärtner W; Feige K; Pietschmann T; Cavalleri JM; Steinmann E
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2430-E2439. PubMed ID: 28275093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
    Keck ZY; Xia J; Wang Y; Wang W; Krey T; Prentoe J; Carlsen T; Li AY; Patel AH; Lemon SM; Bukh J; Rey FA; Foung SK
    PLoS Pathog; 2012; 8(4):e1002653. PubMed ID: 22511875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.
    Mizukoshi E; Nascimbeni M; Blaustein JB; Mihalik K; Rice CM; Liang TJ; Feinstone SM; Rehermann B
    J Virol; 2002 Jun; 76(12):6093-103. PubMed ID: 12021342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.